Biotech takeover target Abivax sinks over 43% as cancer cases cloud trial data for bowel disease drug
A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.
Original Source
Read the full article at Cnbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.